Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 22443860)

1.

Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, Weiss RD.

Am J Drug Alcohol Abuse. 2012 May;38(3):246-50. doi: 10.3109/00952990.2012.670866. Epub 2012 Mar 26.

2.

Rapid cognitive screening of patients with substance use disorders.

Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD.

Exp Clin Psychopharmacol. 2009 Oct;17(5):337-44. doi: 10.1037/a0017260.

3.

Test accuracy of short screening tests for diagnosis of delirium or cognitive impairment in an acute stroke unit setting.

Lees R, Corbet S, Johnston C, Moffitt E, Shaw G, Quinn TJ.

Stroke. 2013 Nov;44(11):3078-83. doi: 10.1161/STROKEAHA.113.001724. Epub 2013 Aug 29.

4.

Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes.

Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7. doi: 10.1136/jnnp-2012-302217. Epub 2012 Jul 31.

PMID:
22851612
5.

Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia.

Freitas S, Simões MR, Alves L, Duro D, Santana I.

J Geriatr Psychiatry Neurol. 2012 Sep;25(3):146-54. doi: 10.1177/0891988712455235. Epub 2012 Aug 1.

PMID:
22859702
6.

Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke.

Dong Y, Venketasubramanian N, Chan BP, Sharma VK, Slavin MJ, Collinson SL, Sachdev P, Chan YH, Chen CL.

J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):580-5. doi: 10.1136/jnnp-2011-302070. Epub 2012 Apr 11.

PMID:
22496580
7.

Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.

Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G.

Stroke. 2011 Jun;42(6):1712-6. doi: 10.1161/STROKEAHA.110.606277. Epub 2011 Apr 7.

8.

[Neurocognitive screening in substance addicts: the Montreal Cognitive Assessment].

Rojo-Mota G, Pedrero-Perez EJ, Ruiz-Sanchez de Leon JM, Llanero-Luque M, Puerta-Garcia C.

Rev Neurol. 2013 Feb 1;56(3):129-36. Spanish.

9.

The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: psychometric properties and association with rehabilitation outcomes.

Sweet L, Van Adel M, Metcalf V, Wright L, Harley A, Leiva R, Taler V.

Int Psychogeriatr. 2011 Dec;23(10):1582-91. doi: 10.1017/S1041610211001451. Epub 2011 Aug 1.

PMID:
21801472
10.

Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.

Lee JY, Dong Woo Lee, Cho SJ, Na DL, Hong Jin Jeon, Kim SK, You Ra Lee, Youn JH, Kwon M, Lee JH, Maeng Je Cho.

J Geriatr Psychiatry Neurol. 2008 Jun;21(2):104-10. doi: 10.1177/0891988708316855.

PMID:
18474719
11.

Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.

Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, Inagaki H, Iwasa H, Ura C, Yatomi N, Ishii K, Tokumaru AM, Homma A, Nasreddine Z, Shinkai S.

Geriatr Gerontol Int. 2010 Jul;10(3):225-32. doi: 10.1111/j.1447-0594.2010.00585.x. Epub 2010 Feb 4.

PMID:
20141536
12.

Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment.

Koski L.

Cerebrovasc Dis. 2013;36(1):6-18. doi: 10.1159/000352051. Epub 2013 Jul 30.

13.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
14.

Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment.

Memória CM, Yassuda MS, Nakano EY, Forlenza OV.

Int J Geriatr Psychiatry. 2013 Jan;28(1):34-40. doi: 10.1002/gps.3787. Epub 2012 Feb 27.

PMID:
22368034
15.

Construct Validity of the Montreal Cognitive Assessment (MoCA).

Freitas S, Simões MR, Marôco J, Alves L, Santana I.

J Int Neuropsychol Soc. 2012 Mar;18(2):242-50. doi: 10.1017/S1355617711001573. Epub 2011 Nov 24.

PMID:
22115097
16.

Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation.

Gillen RW, Kranzler HR, Kadden RM, Weidenman MA.

J Subst Abuse Treat. 1991;8(4):247-51.

PMID:
1664866
17.
18.

Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings.

Hu JB, Zhou WH, Hu SH, Huang ML, Wei N, Qi HL, Huang JW, Xu Y.

Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):38-43. doi: 10.1016/j.archger.2012.05.008. Epub 2012 Jun 13.

PMID:
22698678
19.

Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases.

Olson RA, Chhanabhai T, McKenzie M.

Support Care Cancer. 2008 Nov;16(11):1273-8. doi: 10.1007/s00520-008-0431-3. Epub 2008 Mar 12.

PMID:
18335256
20.

Screening for cognitive impairment in a stroke prevention clinic using the MoCA.

Mai LM, Oczkowski W, Mackenzie G, Shuster A, Wasielesky L, Franchetto A, Patlas M, Sahlas DJ.

Can J Neurol Sci. 2013 Mar;40(2):192-7.

PMID:
23419567
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk